Switch to:
Alexion Pharmaceuticals Inc (NAS:ALXN)
EV/EBITDA
42.03 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Alexion Pharmaceuticals Inc's enterprise value is $36,091 Mil. Alexion Pharmaceuticals Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2016 was $859 Mil. Therefore, Alexion Pharmaceuticals Inc's EV/EBITDA ratio for today is 42.03.

ALXN' s EV/EBITDA Range Over the Past 10 Years
Min: -145   Max: 258.3
Current: 42.03

-145
258.3

During the past 13 years, the highest EV/EBITDA Ratio of Alexion Pharmaceuticals Inc was 258.30. The lowest was -145.00. And the median was 41.90.

ALXN's EV/EBITDA is ranked lower than
71% of the 304 Companies
in the Global Biotechnology industry.

( Industry Median: 21.30 vs. ALXN: 42.03 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Alexion Pharmaceuticals Inc's stock price is $150.42. Alexion Pharmaceuticals Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2016 was $0.72. Therefore, Alexion Pharmaceuticals Inc's P/E Ratio for today is 208.34.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Alexion Pharmaceuticals Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=36090.692/858.604
=42.03

Alexion Pharmaceuticals Inc's current Enterprise Value is $36,091 Mil.
Alexion Pharmaceuticals Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2016 was 193.826 (Jun. 2015 ) + 209.052 (Sep. 2015 ) + 191.455 (Dec. 2015 ) + 264.271 (Mar. 2016 ) = $859 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Alexion Pharmaceuticals Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=150.42/0.722
=208.34

Alexion Pharmaceuticals Inc's share price for today is $150.42.
Alexion Pharmaceuticals Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2016 was 0.83 (Jun. 2015 ) + -0.81 (Sep. 2015 ) + 0.292 (Dec. 2015 ) + 0.41 (Mar. 2016 ) = $0.72.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Alexion Pharmaceuticals Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda -11.12-34.1863.1943.3642.3851.2940.6044.3638.0063.53

Alexion Pharmaceuticals Inc Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
ev2ebitda 44.3643.7139.7637.0038.0040.1454.8950.3563.5339.32
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK